Literature DB >> 20869969

Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection.

Heinrich Taegtmeyer1, William C Stanley.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20869969      PMCID： PMC3019257          DOI： 10.1016/j.yjmcc.2010.09.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  24 in total

1.  Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism.

Authors:  R J BING; A SIEGEL; I UNGAR; M GILBERT
Journal:  Am J Med       Date:  1954-04       Impact factor: 4.965

2.  Diet and cardiovascular disease prevention the need for a paradigm shift.

Authors:  Frank B Hu
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

3.  Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver.

Authors:  So-Young Park; You-Ree Cho; Brian N Finck; Hyo-Jeong Kim; Takamasa Higashimori; Eun-Gyoung Hong; Mi-Kyung Lee; Cheryl Danton; Swati Deshmukh; Gary W Cline; Julie J Wu; Anton M Bennett; Beverly Rothermel; April Kalinowski; Kerry S Russell; Young-Bum Kim; Daniel P Kelly; Jason K Kim
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

4.  [5-3H]glucose overestimates glycolytic flux in isolated working rat heart: role of the pentose phosphate pathway.

Authors:  G W Goodwin; D M Cohen; H Taegtmeyer
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-03       Impact factor: 4.310

5.  Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery.

Authors:  Joshua G Leichman; Erik B Wilson; Terry Scarborough; David Aguilar; Charles C Miller; Sherman Yu; Mohamed F Algahim; Manuel Reyes; Frank G Moody; Heinrich Taegtmeyer
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

Review 6.  Role of diet and fuel overabundance in the development and progression of heart failure.

Authors:  David J Chess; William C Stanley
Journal:  Cardiovasc Res       Date:  2008-03-14       Impact factor: 10.787

Review 7.  Lipotoxicity in the heart.

Authors:  Adam R Wende; E Dale Abel
Journal:  Biochim Biophys Acta       Date:  2009-10-08

Review 8.  Cardiac energy metabolism in obesity.

Authors:  Gary D Lopaschuk; Clifford D L Folmes; William C Stanley
Journal:  Circ Res       Date:  2007-08-17       Impact factor: 17.367

Review 9.  omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.

Authors:  Monika K Duda; Karen M O'Shea; William C Stanley
Journal:  Cardiovasc Res       Date:  2009-05-27       Impact factor: 10.787

Review 10.  Shotgun lipidomics of neutral lipids as an enabling technology for elucidation of lipid-related diseases.

Authors:  Richard W Gross; Xianlin Han
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-06       Impact factor: 4.310
View more
  20 in total

1.  Roles of saturated vs. polyunsaturated fat in heart failure survival: not all fats are created equal.

Authors:  Ganesh V Halade; Yu-Fang Jin; Merry L Lindsey
Journal:  Cardiovasc Res       Date:  2011-11-08       Impact factor: 10.787

Review 2.  Modulating fatty acid oxidation in heart failure.

Authors:  Vincenzo Lionetti; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2011-02-02       Impact factor: 10.787

Review 3.  Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Authors:  William C Stanley; Erinne R Dabkowski; Rogerio F Ribeiro; Kelly A O'Connell
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

4.  Changes in myofilament proteins, but not Ca²⁺ regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure.

Authors:  Y Cheng; W Li; T A McElfresh; X Chen; J M Berthiaume; L Castel; X Yu; D R Van Wagoner; M P Chandler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-15       Impact factor: 4.733

5.  Lipotoxicity and the development of heart failure: moving from mouse to man.

Authors:  William C Stanley; Fabio A Recchia
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

6.  TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling.

Authors:  Junqin Chen; Martin E Young; John C Chatham; David K Crossman; Louis J Dell'Italia; Anath Shalev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

7.  Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Christopher T Sibley; Alain G Bertoni
Journal:  Circ Heart Fail       Date:  2013-03-25       Impact factor: 8.790

8.  Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.

Authors:  Kathleen Guglielmino; Kaleena Jackson; Todd R Harris; Vincent Vu; Hua Dong; Gavin Dutrow; James E Evans; James Graham; Bethany P Cummings; Peter J Havel; Nipavan Chiamvimonvat; Sanda Despa; Bruce D Hammock; Florin Despa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-03       Impact factor: 4.733

9.  Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice.

Authors:  Joshua Abd Alla; Muriel Graemer; Xuebin Fu; Ursula Quitterer
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

Review 10.  The unfolded protein response in ischemic heart disease.

Authors:  Xiaoding Wang; Lin Xu; Thomas G Gillette; Xuejun Jiang; Zhao V Wang
Journal:  J Mol Cell Cardiol       Date:  2018-02-20       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.